HCPCS Level IIdrugActive
J2360
Orphenadrine injection
BETOS: O1E
Effective: 1997-01-01
Description
Injection, orphenadrine citrate, up to 60 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Orphenadrine Citrate Injection
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
60 MG
Billing Units
1.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.